C57BL/6JCya-Timd4em1/Cya
Common Name
Timd4-KO
Product ID
S-KO-08928
Backgroud
C57BL/6JCya
Strain ID
KOCMP-276891-Timd4-B6J-VA
When using this mouse strain in a publication, please cite “Timd4-KO Mouse (Catalog S-KO-08928) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Timd4-KO
Strain ID
KOCMP-276891-Timd4-B6J-VA
Gene Name
Product ID
S-KO-08928
Gene Alias
Tim4, TIM-4, B430010N18Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 11
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000068877
NCBI RefSeq
NM_178759
Target Region
Exon 2~3
Size of Effective Region
~2.4 kb
Overview of Gene Research
Timd4, also known as T cell immunoglobulin and mucin domain containing 4, is a gene with diverse functions. It is involved in processes such as apoptotic cell clearance, phagocytosis, and macrophage-related activities. In macrophages, it may be associated with the Wnt/β-catenin pathway, and has been linked to the regulation of lipid metabolism as indicated by its association with triglyceride levels [1,2].
In a mouse model of periodontitis, Tim4 deficiency led to a reduction in CD301b+ macrophages and aggravated alveolar bone resorption, suggesting that Timd4 controls CD301b+ macrophages through the p38 MAPK signaling pathway [3]. In broad-spectrum antibiotics-treated mice, the down-regulation of Timd4 in large peritoneal macrophages (LPMs) impaired efferocytosis, and oral butyrate rescued this effect, highlighting its role in homeostatic efferocytosis [4]. In the context of anti-tumor immunity, Tim-4+ cavity-resident macrophages sequestered anti-tumor CD8+ T cells and suppressed their proliferation, and Tim-4 blockade enhanced anti-tumor efficacy in mouse models of immunotherapy [5].
In conclusion, Timd4 plays crucial roles in multiple biological processes including macrophage-mediated functions, efferocytosis, and anti-tumor immunity. The use of gene-knockout mouse models has been instrumental in revealing these functions, providing insights into its potential as a therapeutic target in diseases such as periodontitis, inflammatory diseases related to efferocytosis, and cancer immunotherapy.
References:
1. Li, Yi, Zhang, Pei-Yi, Yang, Zhao-Wen, Ma, Fang, Li, Fa-Xin. 2020. TIMD4 exhibits regulatory capability on the proliferation and apoptosis of diffuse large B-cell lymphoma cells via the Wnt/β-catenin pathway. In The journal of gene medicine, 22, e3186. doi:10.1002/jgm.3186. https://pubmed.ncbi.nlm.nih.gov/32187802/
2. Khounphinith, Eksavang, Yin, Rui-Xing, Cao, Xiao-Li, Wu, Jin-Zhen, Li, Hui. 2019. TIMD4 rs6882076 SNP Is Associated with Decreased Levels of Triglycerides and the Risk of Coronary Heart Disease and Ischemic Stroke. In International journal of medical sciences, 16, 864-871. doi:10.7150/ijms.31729. https://pubmed.ncbi.nlm.nih.gov/31337960/
3. Wang, Ziming, Zeng, Hao, Wang, Can, Zhao, Qin, Zhang, Yufeng. 2024. Tim4 deficiency reduces CD301b+ macrophage and aggravates periodontitis bone loss. In International journal of oral science, 16, 20. doi:10.1038/s41368-023-00270-z. https://pubmed.ncbi.nlm.nih.gov/38418808/
4. Saavedra, Pedro H V, Trzeciak, Alissa J, Lipshutz, Allie, Rudensky, Alexander Y, Perry, Justin S A. 2024. Broad-spectrum antibiotics disrupt homeostatic efferocytosis. In Nature metabolism, 6, 1682-1694. doi:10.1038/s42255-024-01107-7. https://pubmed.ncbi.nlm.nih.gov/39122784/
5. Chow, Andrew, Schad, Sara, Green, Michael D, Rudin, Charles M, Merghoub, Taha. 2021. Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity. In Cancer cell, 39, 973-988.e9. doi:10.1016/j.ccell.2021.05.006. https://pubmed.ncbi.nlm.nih.gov/34115989/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
